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Abstract
Background: Cucurbitacins are plant natural products that inhibit activation of the Janus kinase 2 (JAK2)/signal transducer
and activator of transcription 3 (STAT3) pathway by an unknown mechanism. They are also known to cause changes in the
organization of the actin cytoskeleton.
Methodology/Principal Findings: We show that cucurbitacin I potently inhibits the migration of Madin-Darby canine
kidney (MDCK) cell sheets during wound closure, as well as the random motility of B16-F1 mouse melanoma cells, but has
no effect on movement of Dictyostelium discoideum amoebae. Upon treatment of MDCK or B16-F1 cells with cucurbitacin I,
there is a very rapid cessation of motility and gradual accumulation of filamentous actin aggregates. The cellular effect of
the compound is similar to that observed when cells are treated with the actin filament-stabilizing agent jasplakinolide.
However, we found that, unlike jasplakinolide or phallacidin, cucurbitacin I does not directly stabilize actin filaments. In in
vitro actin depolymerization experiments, cucurbitacin I had no effect on the rate of actin filament disassembly at the
nanomolar concentrations that inhibit cell migration. At elevated concentrations, the depolymerization rate was also
unaffected, although there was a delay in the initiation of depolymerization. Therefore, cucurbitacin I targets some factor
involved in cellular actin dynamics other than actin itself. Two candidate proteins that play roles in actin depolymerization
are the actin-severing proteins cofilin and gelsolin. Cucurbitacin I possesses electrophilic reactivity that may lead to chemical
modification of its target protein, as suggested by structure-activity relationship data. However, mass spectrometry revealed
no evidence for modification of purified cofilin or gelsolin by cucurbitacin I.
Conclusions/Significance: Cucurbitacin I results in accumulation of actin filaments in cells by a unique indirect mechanism.
Furthermore, the proximal target of cucurbitacin I relevant to cell migration is unlikely to be the same one involved in
activation of the JAK2/STAT3 pathway.
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Introduction
Cucurbitacins are plant triterpenoids with a number of
interesting biological properties. They possess antiproliferative
and/or cytotoxic activity against various cancer cells (for a
review, see [1]) and anti-inflammatory activity [2,3,4,5,6].
Cucurbitacins selectively inhibit the activation of the Janus kinase
2 (JAK2)/signal transducer and activator of transcription 3
(STAT3) signal transduction pathway but does not directly bind
and inhibit these proteins [7,8,9,10,11,12,13]. Cucurbitacins have
been shown to cause considerable changes in the organization of
the actin cytoskeleton in cells, including disruption or rearrange-
ment of normal actin networks and formation of abnormal actin
aggregates [10,14,15,16,17,18,19,20,21,22]. In addition, cucur-
bitacins can affect cell adhesion [23].
While screening the National Cancer Institute (NCI) Diversity
Set, we identified cucurbitacin I (NSC 521777; JSI-124; elataricin
B) as a potent inhibitor of cell migration in a Madin-Darby canine
kidney (MDCK) cell wound closure assay. Cucurbitacin I has also
been shown to inhibit the migration of keloid fibroblasts [24,25].
Assembly and disassembly of actin filaments is required for cell
migration, and compounds that affect polymerization of actin or
the stability of actin filaments inhibit the motility of cells (for
reviews, see [26,27]). This may be the mechanism by which
cucurbitacin I inhibits the movement of cells, but it is as yet
unknown how cucurbitacin I mediates its effects on the
cytoskeleton. While one report provides evidence that cucurbitacin
E may directly stabilize existing actin filaments in vitro [20], it is far
from clear if this alone accounts for the full extent of dramatic
actions of cucurbitacins on the actin cytoskeleton in the cell.
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14039We show that cucurbitacin I inhibits the migration of MDCK
cells and B16-F1 mouse melanoma cells, although it has no effect
on Dictyostelium discoideum cells. Cucurbitacin I caused actin
aggregation in MDCK and B16-F1 cells, yet had no direct effect
on purified actin polymerization or depolymerization in vitro.
Cucurbitacins A, B, and C lacked anti-migratory activity against
MDCK cells, although they still possessed cytotoxic activity. These
results indicate that in cells, cucurbitacin I has an indirect effect on
actin dynamics that leads to an over-accumulation of actin, most
likely by interfering with actin depolymerization.
Results
A high throughput wound closure assay with MDCK cells was
used to screen the NCI Diversity Set for inhibitors that slowed the
rate of cell migration [28]. The most potent hits were evaluated for
cytotoxicity, and those with clear subtoxic activity were investi-
gated further. Cucurbitacin I (NSC 521777; structure in Figure 1)
was among these compounds (Figure 2 and Table 1). In contrast,
cucurbitacins A, B, and C displayed no clear subtoxic antimi-
gratory activity, although they were cytotoxic at higher concen-
trations (Table 1).
We imaged the wound closure process in MDCK cells
expressing mCherry-actin by time-lapse fluorescence microscopy
(Figure 3 and Movie S1). The wound closed steadily at about
0.45 mm/min for 2 h in the absence of compound. Upon addition
of the compound, wound edge translocation was greatly inhibited,
and actin aggregates began to accumulate in the cells. By 2 h after
addition of compound, the rate of closure decreased to 0.1 mm/
min. After several more hours, the wound edge again began to
slowly move into the open area; however, instead of maintaining a
consistent front, some areas advanced while others retracted as if
the sheet had lost adhesive continuity.
We next looked at the effect of cucurbitacin I on motile B16-F1
melanoma cells and Dictyostelium discoideum amoebae. When
200 nM cucurbitacin I was applied to migrating B16-F1 cells,
translocation rapidly ceased (Movies S2 and S3). After 45 min, the
compound was washed out, but it took about an hour before the
first cells began to regain movement. Full recovery of the
population occurred gradually over the next 5 h. When imaged
at higher temporal and spatial resolution, lamellipodial ruffling
and protrusion stopped within 30 s of treatment with cucurbitacin
I, and within 1 min the lamellipodia began to retract (Figure 4 and
Movie S3). Within 10 min, the cells had become rounded and
small blebs appeared around the periphery. We then tested the
effect of cucurbitacin I on the motility of Dictyostelium amoebae. No
significant change in average speed or cell morphology were seen
at concentrations as high as 2 mM cucurbitacin I (Figure 5 and
Movie S4).
Having shown that cucurbitacin I has a rapid and reversible
effect on cellular motility in MDCK and B16-F1 cells, changes in
the localization of actin-containing structures were examined in
compound-treated cells expressing mCherry-actin. During wound
closure in MDCK cell monolayers, punctate fluorescent structures
appeared in the cytoplasm after addition of cucurbitacin I
(Figure 3). In low-density MDCK cell cultures, mCherry-actin
produced a diffuse signal throughout the cytoplasm, with more
intense localization in areas where rapid actin polymerization was
occurring, such as in new protrusions (Figure 6A and Movie S5).
Upon addition of 200 nM cucurbitacin I, cells ceased lamellar
extension, and small punctate aggregates began to form through-
out the cytoplasm (Figure 6A and Movie S5). The aggregates
Figure 1. Structures of cucurbitacins examined in this study.
doi:10.1371/journal.pone.0014039.g001
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decreased, suggesting a shift from actin monomer (globular actin;
G-actin) to actin polymer (filamentous actin; F-actin). Similar
results were obtained when B16-F1 cells expressing mCherry-actin
were treated with the compound (Figure 6B). In cells treated with
200 nM cucurbitacin I for 4 h, aggregates persisted for days after
the compound was washed out (Figure 7). To demonstrate that the
aggregates are formed from F-actin rather than G-actin, cells
treated with cucurbitacin I for 4 h were fixed and stained with
FITC-phalloidin, which only binds F-actin; the aggregates that
were labeled with mCherry-actin were also stained by FITC-
phalloidin (Figure 7E). Cucurbitacin I did not cause actin
aggregates to form in Dictyostelium amoebae (Figure 6C).
The formation of actin aggregates in cucurbitacin I-treated cells
indicates that the compound is having an effect on actin
depolymerization. In an attempt to learn more about the
mechanism by which cucurbitacin I causes actin aggregation, we
compared its effects to that of jasplakinolide, a compound that
directly binds F-actin and stabilizes the filaments. Treatment of
migrating B16-F1 cells with jasplakinolide resulted in cessation of
movement within 5 min (Movie S6), as it does in fibroblasts [29].
Within 2 h of compound addition, cells had retracted all processes
and became rounded. The cells recovered after compound
removal, and after 4 h, they had begun to move again (Movie
S6). Jasplakinolide also caused motility to cease and the formation
of actin aggregates in MDCK cells (Figure 8A). In B16-F1 cells,
jasplakinolide caused the formation of small actin aggregates, but
the more dramatic effect was the collapse and fragmentation of the
lamellipodium (Figure 8B and Movie S6). This was not observed
with treatment with cucurbitacin I, indicating that the effect of the
compounds on the actin cytoskeleton is likely to be mechanistically
different.
If cucurbitacin I stabilizes F-actin, then this might lead to a
change in the ratio of F- to G-actin in cells. In cells treated for 2 h
with cucurbitacin I, there was a shift in the F-/G-actin ratio from
0.2 to 2.5 (Figure 9). In order to determine whether cucurbitacin I
acts directly on actin filaments or acts indirectly through other
actin-binding proteins, the effect of the compound on purified
actin was measured. The rate of actin polymerization from
pyrene-G-actin in the presence or absence of cucurbitacin I in vitro
was indistinguishable (Figure 10A). To test the effect of the
compounds on actin filament disassembly, pyrene-G-actin was
polymerized to pyrene-F-actin and then diluted to induce
depolymerization in the presence or absence of compound.
Cucurbitacin I at high concentrations had a weak inhibitory effect
on actin depolymerization, but this was much weaker than the
known direct actin-stabilizing compound phallacidin (Figure 10B).
The effect was also qualitatively different from that of phallacidin.
High concentrations of cucurbitacin I seemed to delay the onset of
depolymerization, but once the filaments began to disassemble, the
rates of depolymerization were similar to the DMSO control (note
similar slopes in the presence of cucurbitacin I as in its absence in
Figure 10B). Furthermore, in an in vitro actin depolymerization
assay based instead on pelleting of F-actin, 200 nM cucurbitacin I
had no effect on actin depolymerization, whereas 200 nM
jasplakinolide prevented depolymerization (Figure 10C).
It is not clear what proteins cucurbitacin I interacts with to
prevent actin depolymerization. Two potential candidates are
cofilin and gelsolin, both of which have actin-severing activity and
appear to play roles in actin depolymerization in cells (for a review,
see [30]). The side chains of cucurbitacin I and other cucurbitacins
with potent activity in cellular studies contain a potentially reactive
a,b-unsaturated ketone (Michael acceptor) that appears important
for activity [7,14,31] and likely alkylates target proteins. Purified
cofilin or gelsolin were treated with cucurbitacin I and subjected to
liquid chromatography (LC)-electrospray ionization (ESI)-mass
spectrometry (MS), as described in Materials and Methods.
Neither protein showed a change in mass after compound
Figure 2. Cucurbitacin I inhibits cell sheet migration during wound closure of MDCK epithelial cell monolayers in a dose-dependent
manner. The progress of wound closure in MDCK cell monolayers was followed in the presence of different concentrations of cucurbitacin I. Values
represent the mean with standard error of the mean for the indicated number of wounds.
doi:10.1371/journal.pone.0014039.g002
Table 1. Activity of cucurbitacins in MDCK cells.
Compound IC50
a 95% CI
b MIC
c MLC
d
Cucurbitacin I
(NSC 521777)
151 nM 97 nM–234 nM 50 nM 500 nM
Cucurbitacin A
(NSC 94743)
NA NA 500 nM 2,000 nM
Cucurbitacin B
(NSC 49451)
NA NA 500 nM 1,000 nM
Cucurbitacin C
(NSC 94744)
NA NA 500 nM 1,000 nM
aHalf-maximal inhibitory concentration (IC50) values relative to the maximal
response were calculated for inhibition of wound closure at 24 h post-
wounding from data for the range of subtoxic concentrations.
b95% confidence interval (CI).
cMinimum inhibitory concentration (MIC).
dMinimal lethal concentration (MLC).
doi:10.1371/journal.pone.0014039.t001
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covalently to either protein.
Discussion
Previously published data has shown that cucurbitacin I
inhibits activation of the JAK2/STAT3 signal transduction
pathway but does not appear to directly inhibit JAK2 kinase
activity or STAT3’s function as a transcription factor
[7,8,9,10,11,12,13]. It is likely that cucurbitacin I acts upstream
of JAK2 and STAT3 by inhibiting some as-yet undefined
component of this pathway or that the compound indirectly
affects the pathway by inhibiting some factor that may feed into
or modulate the pathway. Cucurbitacins B and D have also been
shown to antagonize Drosophila steroid hormone binding to the
ecdysone receptor [32]. Cucurbitacins have dramatic effects on
the organization of the actin cytoskeleton, resulting in alterations
in the cell’s normal actin networks and formation of actin
aggregates [10,14,15,16,17,18,19,20,21,22], although the mech-
anism by which this occurs is unknown. Cucurbitacins have also
been reported to inhibit cell adhesion [23].
We have shown that cucurbitacin I is a potent inhibitor of cell
motility that also disrupts normal actin dynamics. It is unknown
whether cucurbitacin I’s effect on the JAK2 pathway and STAT3-
dependent transcription is independent or interdependent of its
effects on the actin cytoskeleton. It is well known that altering
transcription takes hours to affect the cell. Our data has shown
that inhibition of motility and the compound’s effects on the
cytoskeleton occur within seconds to minutes of compound
addition. This suggests that cucurbitacin I’s effect on transcription
does not cause motility inhibition or cytoskeletal abnormalities. It
is possible that cucurbitacin I’s disruption of the cytoskeleton may
Figure 3. Cucurbitacin I affects the morphology of the wound edge and actin cytoskeletal organization in MDCK cell monolayers.
mCherry-actin-expressing MDCK cells were grown to confluence and the monolayer was then wounded. Images of the wound edge every 5 min for
5 h without compound and then for 19 h in the presence of 200 nM cucurbitacin I. Wound closure ceased following addition of the compound and
the cells began to accumulate actin aggregates. Time ‘‘0 h’’ in this figure corresponds to the time of compound addition, which is 5 h in Movie S1.
doi:10.1371/journal.pone.0014039.g003
Figure 4. Cucurbitacin I inhibits motility of B16-F1 melanoma cells. Phase-contrast images of migrating B16-F1 cells were captured every
30 s on a laminin-coated dish. 200 nM cucurbitacin I was then added to the chamber. The panels show representative time points before and after
compound addition with ‘‘0 h’’ being when compound was added.
doi:10.1371/journal.pone.0014039.g004
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both caused by one upstream target because it is unlikely that
cucurbitacin I binds to two different target molecules, one that
controls transcription and one that regulates actin.
One of the most striking cellular abnormalities observed
following treatment with cucurbitacin I is the formation of large
cytoplasmic actin aggregates. After about 1 h of compound
incubation, actin structures appear thicker throughout the
cytoplasm. Some of these structures look similar to stress fibers.
As treatment continues, these fibers seem to condense into
aggregates. Once these aggregates have formed, they persist
within the cell for several days after compound removal. It is
tempting to speculate that these aggregates would cause a defect in
cell motility, but that seems not to be the case. Interestingly, the
inhibition of motility and formation of aggregates occur at within
drastically different time frames over the course of treatment.
Inhibition of motility occurs within minutes while aggregate
formation does not begin until at least 1 h of treatment. This
indicates that the aggregates themselves are not what cause the
cells to cease translocation. In fact, our data has shown that cells
will recover movement after compound removal while cytoplasmic
aggregates are still present. Thus, the inhibition of motility is a
short term and reversible effect whereas actin aggregation is a
longer-term effect.
Cucurbitacin I does not have any apparent effect on migration
of the cellular amoeba Dictyostelium discoideum. Despite overnight
incubation in 1.2 mM cucurbitacin I, Dictyostelium do not show
changes in motility or cytoskeletal morphology. In contrast, actin
aggregates do form in Dictyostelium and other cells following
treatment with actin-stabilizing compound jasplakinolide [33,34].
Dictyostelium is often used as model systems for higher organisms
because this organism contains many proteins that are orthologous
to mammalian proteins. The fact that Dictyostelium is not affected
by cucurbitacin I suggests that the target of cucurbitacin I does not
have a close homolog in Dictyostelium. This is consistent with the
observation that cucurbitacin I does not directly stabilize actin
because actin is highly conserved between Dictyostelium and
mammalian cells.
In an attempt to further characterize the effects of cucurbitacin
I, we compared its action to that of actin-stabilizing compound,
jasplakinolide. Aggregates caused by jasplakinolide were visually
indistinguishable from those induced by cucurbitacin I. We have
found that although both of these compounds have similar
downstream effects, they do not act by the same mechanism.
While jasplakinolide directly stabilizes F-actin in vivo and in vitro,
cucurbitacin I has only a weak effect in vitro and only at high
concentrations in the pyrene-actin depolymerization assay, similar
to the results reported by Momma et al. for cucurbitacin E [20].
Cucurbitacin I’s activity in cells is orders of magnitude greater
than this weak activity in vitro. Moreover, the weak stabilization of
actin filaments at high concentrations of cucurbitacin I is
qualitatively different from the effects of phallacidin: the initiation
of depolymerization is delayed but once depolymerization begins,
it appears to do so at the same rate as the control. It is hard to
imagine that even with the possibility of sequestration of
cucurbitacin I in the cell to high local concentrations, any direct
actin-stabilizing activity of cucurbitacin I could explain the highly
potent activity of cucurbitacin in cells, nor would it explain
cucurbitacin I’s ability to selectively inhibit activation of the
JAK2/STAT3 pathway. Cucurbitacin I more likely targets other
proteins that are involved in signaling and the regulation of actin
depolymerization.
Cucurbitacins A, B, and C – all of which have an acetylated side
chain in addition to other differences from cucurbitacin I – did not
possess subtoxic antimigratory activity against MDCK cells. The
potentially reactive Michael acceptor function of the side chain of
the most bioactive cucurbitacins in a number of cellular studies
appears important for activity [7,14,31]. These cucurbitacins may
covalently bind target proteins. Two potential candidates whose
inhibition would be consistent with the observed activity of
cucurbitacin I are the actin-severing and actin-depolymerization-
promoting proteins cofilin and gelsolin (for a review, see [30]). We
Figure 5. Cucurbitacin I does not affect the motility of Dictyostelium amoebae. Dictyostelium cells were plated in growth medium and
allowed to attach for 1 h. Images were captured every 15 s for 1 h, and then cucurbitacin I was added to 200 nM. Imaging was continued for 1.5 h
and then the concentration of cucurbitacin I was raised to 2 mM and imaging continued for another 1.5 h. The graph shows the smoothed speeds of
two representative cells from Movie S4). There was no significant difference between the mean speed of the population of cells in the presence or
absence of the compound (control, 6.263.1 mm/min; 200 nM cucurbitacin I, 6.363.5 mm/min; 2 mM cucurbitacin I, 6.063.2 mm/min; n=6 cells for all
treatments).
doi:10.1371/journal.pone.0014039.g005
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cofilin or gelsolin.
Nakashima et al. found that the Michael acceptor on the side
chain of cucurbitacin E was important for its potent antiprolifer-
ative activity, and they pulled down cofilin from cell extracts with a
biotinylated derivative of cucurbitacin E, although it is not clear if
the interaction is direct or indirect [31]. They showed that
cucurbitacin E blocks the inactivating phosphorylation of cofilin,
which would be expected to result in increased cellular cofilin
activity [31]. The alterations in cellular F-actin that could arise as
a result of changing cofilin activity are particularly complex. While
increasing cofilin activity would be expected to result in more
filament severing, it may or may not result in reduced F-actin
content. In fact, severing by cofilin has been proposed to play a
major role in the generation of new barbed ends, which would
elongate to increase lamellipodial F-actin (for a review, see [35]).
Nakashima et al. also found decreased F-actin in HT1080
fibrosarcoma cells [31], contrary to our data and those of others
[18,19,20] demonstrating actin aggregation and increased F-actin
in cells treated with cucurbitacins.
Interestingly, Nakashima et al. found that cucurbitacin I had
much lower potency than cucurbitacin E in inhibition of cofilin
phosphorylation and effects on actin [31], which may suggest a
different profile of specific cellular targets. Cucurbitacin I and
Figure 6. Cucurbitacin I causes actin aggregation in MDCK and B16-F1 cells. (A) mCherry-actin-expressing MDCK cells were plated at low
density and then imaged before (0 h) and after addition of 200 nM cucurbitacin I. Images were collected every 5 min for 4.5 h. Cells cease to move
and then begin to accumulate actin aggregates within 1 h of compound addition. (B) mCherry-actin-expressing B16-F1 cells were treated with 25 nM
cucurbitacin I. The cells ceased to move and actin aggregates began to accumulate within 1 h of compound addition. (C) Dictyostelium cells
expressing the F-actin probe dRFP-FilABD were plated in Petri dishes at low density in HL5 growth media and allowed to settle for several hours. Cells
were then placed in 1 mL of medium containing: (A) 0.25% DMSO; (B) 100 nM cucurbitacin I; (C) 1.25 mM cucurbitacin I. Cells were incubated
overnight at 21uC and then imaged. No aggregate formation or other alterations of the actin cytoskeleton were observed.
doi:10.1371/journal.pone.0014039.g006
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cucurbitacins A, B, and C) on the terminal alcohol of the side
chain that constitutes part of the putative pharmacophore of these
molecules. Thus, these two cucurbitacins may have somewhat
different target selectivity. While cofilin or an associated protein
may be a target of cucurbitacin E, the activities described by
Nakashima et al. [31] do not explain the F-actin-stabilizing effects
of cucurbitacins or their inhibitory effects on the JAK2/STAT3
Figure 7. Actin aggregates persist after removal of cucurbitacin I. B16-F1 cells expressing mCherry-actin were imaged before (A) and after
4 h in the presence of 200 nM cucurbitacin I (B). The compound was then washed out and imaging continued. Images are shown at (C) 24 h and (D)
40 h after washout. Each panel is a maximum-intensity projection of 7 confocal Z sections through a representative cell. (E) After 4 h in cucurbitacin I,
one sample of B16-F1 cells was fixed and stained with fluorescein-conjugated phalloidin to visualize F-actin. A single confocal Z slice showing the
aggregates stained with fluorescein-phalloidin (left panel), mCherry-actin (center panel) is shown along with a differential interference contrast (DIC)
image (right panel).
doi:10.1371/journal.pone.0014039.g007
Figure 8. Jasplakinolide inhibits cell motility and causes actin aggregates to form. (A) MDCK cells were plated at low density and imaged
as in Figure 5A but in the presence of 200 nM jasplakinolide. The cells cease to move and actin aggregates begin forming within 1 h of compound
addition. (B) B16-F1 cells were imaged as in Figure 5B but in the presence of 200 nM jasplakinolide. Cells were spread and moving before addition of
jasplakinolide but ceased to move and accumulated actin aggregates within 1 h of treatment with compound. The cells also showed fragmentation
of the lamellipodium, which was not observed in cells treated with cucurbitacin I.
doi:10.1371/journal.pone.0014039.g008
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cins remain to be identified. Such a target could be an upstream or
feedback component of the JAK2/STAT3 pathway that also
regulates the stability of actin filaments, or else the different
activities of cucurbitacins may result from the targeting of separate
proteins. Given the very rapid kinetics of inhibition of cell motility,
the latter possibility appears more likely.
Materials and Methods
Compound Preparation and Storage
The NCI Diversity Set and solid samples of cucurbitacins A, B,
C, and I were kindly provided by the NCI. Stock solutions of
10 mM cucurbitacins A, B, C, and I in dimethyl sulfoxide
(DMSO) were prepared from the desiccated solid samples. Stock
solutions were stored in a desiccator at 220uC and used within 2
months of preparation.
Cell Lines and Vectors
Dictyostelium discoideum strain amoebae were grown in HL5
nutrient media [36] at 21uC. To image actin dynamics, cells were
transfected with dRFP-FilABD, which behaves similarly to the
GFP-FilABD probe previously described [37]. The probe was
made by isolating the actin-binding domain of Dictyostelium
filamin by PCR using forward primer 59-CAGTAGGATC-
CATGGCTGCTGCTCCAAGT-39 and reverse primer 59-
TACGCTCTAGAGGCATCTGAAGTTTC-39. These primers
added BamHI and XbaI sites, allowing the fragment to be ligated
into dRFP-pDXA-3H-Hygro [38] into which dimer2 RFP [39]
had already been inserted (pDXA-dRFP). MDCK cells, either
‘‘normal’’ or stably transfected cells expressing mCherry [40] fused
to human b-actin (mCherry-actin), were grown in Minimum
Essential Medium containing 0.1% nonessential amino acids,
ampicillin/streptomycin antibiotics, and 10% fetal bovine serum
(FBS) or newborn calf serum at 37uC and 5% CO2. B16-F1 cells
stably expressing mCherry-actin were grown in Dulbecco’s
Modified Eagle’s Medium with D-glucose, L-glutamine, and
10% FBS at 37uC and 5% CO2.
Imaging and Analysis of Mammalian Cell Migration
Wound closure experiments to evaluate migration of MDCK
cells in the presence of cucurbitacin I (both initial screening and
subsequent quantitative analyses for concentration-response pro-
filing) were carried out as previously described, as were
determinations of cell viability at the end of each experiment [28].
For live-cell imaging, MDCK cells (2610
5) were plated on
Bioptechs chambers (coated with 5 mg/mL laminin) and grown
overnight in bicarbonate-free HAMS-F12 medium with 10% FBS
at 37uC. The medium was replaced with 500 mL fresh bicarbon-
ate-free HAMS-F12 medium buffered with 10 mM HEPES, and
the Bioptechs chambers were placed in a Bioptechs Delta T stage
temperature controller set to 37uC. A single scratch wound was
created in the monolayer by scraping the surface of the dish with a
200-mL pipet tip. The wound was imaged every 5 min for several
hours on an automated Zeiss 200 M inverted microscope with
Openlab software (Perkin-Elmer/Improvision), and then cucurbi-
tacin I was added in an equal volume of new medium for a final
concentration of 200 mM. Images were taken for several more
hours and then analyzed with ImageJ software [41]. The long-
term confocal imaging of aggregates in cells treated with
cucurbitacin I was performed using a Pathology Devices stage
incubator (maintaining 37uC and 5% CO2) on a Nikon A1R
confocal microscope.
To measure random motility, MDCK or B16-F1 cells were
plated on 5 mL/mL laminin-coated Bioptechs chambers at 37uC
at low density and allowed to settle overnight. Imaging was done
before and after addition of an equal volume of medium
containing cucurbitacin I or jasplakinolide to final concentrations
indicated in the figure and movie legends. Motility was analyzed
with ImageJ software and the MTrackJ plugin.
Imaging and Analysis of Dictyostelium Cell Motility and
Cytoskeleton
For analysis of cell speed, Dictyostelium amoebae (strain NC4A2)
were plated on plastic Petri dishes in HL5 growth medium and
allowed to attach for 1 h. Images were captured every 15 s for 1 h,
and then cucurbitacin I was added to 200 nM. Imaging was
continued for 1.5 h, and then the concentration of cucurbtacin I
was raised to 2 mM and imaging continued for another 1.5 h. The
captured images were analyzed with ImageJ software with the
mTrackJ plugin to manually track the movements of representa-
tive cells. The speeds were analyzed with Graphpad Prism by a
Mann-Whitney non-parametric U test.
To determine whether cucurbitacin I causes aggregate forma-
tion, cells expressing dRFP-FilABD were plated in glass-bottom
Petri dishes (Willco Wells) and treated with compound overnight
in HL medium. dRFP-FilABD like GFP-FilABD [37] associates
with F-actin-containing structures in cells, including actin
aggregates induced by jasplakinolide (data not shown). The cells
were imaged with a 1006oil immersion objective.
Determination of G- and F-Actin Levels in Control and
Compound-Treated Cells
Subconfluent MDCK cells were treated overnight with 0.1%
DMSO or 200 nM cucurbitacin I. Cells were harvested into 1.5 mL
tubes and centrifuged at 1,0006gf o r5m i na t4 uC. The media was
aspirated, and the cells were resuspended in 250 ml of lysis buffer
(50 mM PIPES, pH 6.9, 50 mM NaCl, 5 mM MgCl2,5 m M
Figure 9. Cucurbitacin I stabilizes actin filaments in vivo. Cells
were incubated for 2 h with 0.1% DMSO (lanes 1 and 2) or 200 nM
cucurbitacin I (lanes 3 and 4), then harvested, lysed and centrifuged to
separate G actin (supernatant, lanes 1 and 3) from F-actin (pellet, lanes 2 and
4). Samples were electrophoresed on an SDS-polyacrylamide gel, transferred
to a polyvinylidene fluoride membrane and subjected to Western blot
analysis with an anti-b-actin antibody. The ratio of F-actin to G-actin
increased from 0.19 in the control to 2.5 in the cucurbitacin I-treated cells.
doi:10.1371/journal.pone.0014039.g009
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mercaptoethanol, 1 mM ATP, 1 mM phenylmethanesulfonyl fluo-
ride, 5 mg/mL N-a-p-tosyl-L-arginine methyl ester, 10 mg/mL N-p-
tosyl-L-phenylalanine chloromethyl ketone, 80 mg/mL aprotinin,
20 mg/mL pepstatin, 20 mg/mL chymostatin) and incubated on ice
for 30 min. Samples were then centrifuged at 10,0006g for 10 min at
4uC. The supernatant (G-actin) was removed, and the pellet (F-actin)
was resuspended in 250 ml lysis buffer. An equal volume of 2x sodium
dodecylsulfate (SDS)sample buffer was added, and samples heated to
100uC for 5 min. Equal volumes of each sample were then
electrophoresed on a 10% SDS-polyacrylamide gel and electro-
blotted onto a polyvinylidene fluoride membrane. The membrane
was blocked in non-fat dry milk for 1 h and incubated in a 1:500
dilution of mouse anti-b-actin antibody for 1 h, followed by
incubation with a 1:5,000 dilution of goat anti-mouse antibody
conjugated to alkaline phosphatase for 1 h. Colorimetric detection
was achieved with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue
tetrazolium as described previously [42,43].
Actin Polymerization
Actin was purified from rabbit muscle acetone powder as
previously described [44,45], with two additional rounds of
polymerization-depolymerization. Purity was confirmed by SDS-
polyacrylamide gel electrophoresis. The actin was labeled to
,70% with N-(1-pyrene)iodoacetamide (Invitrogen) and used in a
pyrene-actin polymerization assay essentially as previously report-
ed [46,47]. The pyrene-G-actin was stored in 2 mM Tris, pH 8.0,
0.1 mM CaCl2, 0.2 mM ATP, 0.5 mM dithiothreitol (DTT).
Immediately prior to the experiment, ME buffer, consisting of
50 mM MgCl2, 0.2 mM ethylene glycol-bis(2-aminoethyl ether)-
N,N,N9,N9-tetraacetic acid (EGTA), was added to concentration of
16 from a 106 stock of ME buffer to exchange Ca
2+ for Mg
2+.
The sample was incubated in the presence or absence of 50 mM
cucurbitacin I for 1 h at 4uC, with pyrene-G-actin at a final
concentration of 2 mM. Polymerization was then initiated by
addition of a 1/10 volume of 106KMEI buffer (106=500 mM
KCl, 10 mM MgCl2, 10 mM EGTA, 100 mM imidazole,
Figure 10. Cucurbitacin I does not directly affect actin polymerization, depolymerization or steady-state levels of F-actin in vitro. (A)
Pyrene-labeled rabbit muscle G-actin polymerization was measured in the presence or absence of 50 mM cucurbitacin I as described in Materials and
Methods. Values represent the mean with standard deviation (SD) for n=4. The compound had no effect on actin polymerization. (B) Pyrene-G-actin
was polymerized to pyrene-F-actin and then diluted to induce actin filament disassembly, as described in Materials and Methods, in the presence or
absence of cucurbitacin or phallicidin at the indicated concentrations. Phallacidin inhibited actin depolymerization, but cucurbitacin I only weakly
delayed the start of depolymerization and only at relatively high concentrations, while not affecting the rate of depolymerization (note similar slopes
once depolymerization starts). Values represent the mean with SD for n=9. (C) Cucurbitacin I does not directly stabilize F-actin. Purified human non-
muscle G-actin was polymerized to F-actin and then pelleted immediately (lane 1) or after dilution to initiate depolymerization and overnight
incubation in the absence (lane 2) or presence of 200 nM jasplakinolide (lane 3) or 200 nM cucurbitacin I (lane 4). Pellets were solubilized in SDS
sample buffer, and samples were then electrophoresed on an SDS-polyacrylamide gel and stained with Coomassie blue. Jasplakinolide prevented
filament depolymerization, but cucurbitacin I had no effect.
doi:10.1371/journal.pone.0014039.g010
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sion) was measured over time on a fluorescence microplate reader
(BioTek FLx800TBI).
Actin Depolymerization
Lyophilized pyrene-labeled rabbit muscle actin (,50%
pyrene labeled from Cytoskeleton) was resuspended in water
and then diluted to 23 mMi n5m MT r i s ,p H8 . 0 ,0 . 2m M
CaCl2, 0.2 mM ATP. Pyrene-G-actin was polymerized to
pyrene-F-actin according to the manufacturer’s instructions by
addition of a 1/25 volume of 106actin polymerization buffer
(106=500 mM KCl, 20 mM MgCl2,1 0 m MA T P ) .T h e
sample was stored in the dark at room temperature for 1 h.
Depolymerization was initiated by diluting the pyrene-F-actin
25-fold with 5 mM Tris, pH 8.0, 0.2 mM CaCl2,0 . 2 m M
ATP, in the presence or absence of cucurbitacin I or
phallacidin at the concentrations indicated in Fig. 10B.
Fluorescence intensity (340 nm excitation/420 nm emission)
measurements were taken over time on a fluorescence
microplate reader (BioTek FLx800TBI).
As an alternative method to measure actin depolymerization,
actin seeds were formed by incubating 4 mM human non-muscle
G-actin (Cytoskeleton) in ISAP buffer (40 mM PIPES, pH 7.0,
2 mM DTT, 2 mM ATP, 10 mM EGTA, 100 mM KCl, 4 mM
MgCl2) in a total volume of 200 mL overnight on ice. G-actin was
polymerized to F-actin the next morning at room temperature for
1 h by combining 75 mL actin seeds with 75 mLo f4mM G-actin
in 16ISAP buffer. 15 mL aliquots of F-actin were added to tubes,
and then the actin was diluted by addition of 135 ml of 5 mM Tris,
pH 7.8, 0.2 mM CaCl2, 0.2 mM ATP to initiate depolymeriza-
tion in the presence or absence of 200 nM jasplakinolide or
cucurbitacin I. Tubes were incubated overnight at 4uC. Samples
were centrifuged in an airfuge for 1 h, and pellets were
resuspended in 20 mL of SDS sample buffer. Samples were
denatured at 100uC for 5 min and then loaded onto a 10% SDS-
polyacrylamide gel. The gel was stained with GelCode Blue G-250
(Thermo Scientific Pierce) and destained in deionized water.
Bands were quantified with ImageJ software.
Mass Spectrometry
The possibility of covalent association of cucurbitacin I with
purified human cofilin or human plasma gelsolin was examined by
LC-ESI-MS. 15 mM of each protein was incubated with 100 mM
cucurbitacin I for 6 h at 37uC. Each sample, as well as additional
non-treated protein controls, was loaded onto a C18 column
(Hypersil GOLD, 1.9 mm, 100 mm61.0 mm, Thermo Scientific)
on a 10ADvp high-performance LC system (Shimadzu). The
proteins were eluted with a linear gradient from 2% acetonitrile/
water/0.1% acetic acid to 90% acetonitrile/water/0.1% acetic
acid over 20 min at a flow rate of 50 mL/min. The effluent was fed
into the ESI source of a QStar Elite mass spectrometer (Applied
Biosystems/MDS Sciex), with typical source conditions of IS
5500V, GS1 20, DP 80 V, FP 280 V, DP2 15 V. Acquisition of
data was controlled with Analyst software (AB SCIEX).
Supporting Information
Figure S1 Neither cofilin nor gelsolin are alkylated by
cucurbitacin I. Mass spectra of human cofilin and human plasma
gelsolin following incubation of 15 mM of each protein with
100 mM cucurbitacin I for 6 h at 37uC and LC-ESI-MS. The
masses of the cucurbitacin I-treated proteins were identical to
those of non-treated protein controls.
Found at: doi:10.1371/journal.pone.0014039.s001 (1.43 MB TIF)
Movie S1 Inhibition of wound closure in MDCK cells exposed
to cucurbitacin I. mCherry-actin-expressing MDCK cells were
grown to confluence on a Bioptechs dish and the monolayer was
wounded. The wound edge was imaged at 37uC every 5 min for
5 h in the absence of compound, and then the medium was
changed to medium containing 200 nM cucurbitacin I, and the
wound edge was imaged for an additional 19 h.
Found at: doi:10.1371/journal.pone.0014039.s002 (6.52 MB
MOV)
Movie S2 Inhibition of B16-F1 motility by cucurbitacin I. B16-
F1 cells were grown overnight on laminin-coated dishes and then
imaged at 37uC by phase-contrast microscopy. Images were
captured every 3 min for 45 min and then continued following
addition of cucurbitacin I to 100 nM for an another 45 min. The
cells can be seen to rapidly stop movement and retract
protrusions. The compound was then washed out and the cells
were imaged over a 5-h period during which movement gradually
resumed.
Found at: doi:10.1371/journal.pone.0014039.s003 (1.89 MB
MOV)
Movie S3 B16-F1 cells exposed to cucurbitacin I immediately
stop protrusion and begin retraction of lamellae. B16-F1 cells
were imaged at 37uC every 30 s for 3 h by phase-contrast
microscopy and then cucurbitacin I was added to 200 nM while
imaging. The movie shows the 8 min prior to compound
addition and the next 40 min in the presence of compound.
The freezing of protrusion is evident within a minute after
addition of compound, while retraction took place over a longer
time scale.
Found at: doi:10.1371/journal.pone.0014039.s004 (6.03 MB
MOV)
Movie S4 Cucurbitacin I does not affect the motility of
Dictyostelium amoebae. Dictyostelium discoidium (strain NC4A2) were
plated for 1 h in HL5 medium on a Petri dish and then imaged
every 15 s at room temperature. After 1 h, cucurbitacin I was
added to 200 nM, and the cells were imaged for 1.5 h. The
concentration of cucurbitacin I was then raised to 2 mM and
imaging was continued for another 1.5 h.
Found at: doi:10.1371/journal.pone.0014039.s005 (5.15 MB
MOV)
Movie S5 F-actin formation in the presence of cucurbitacin I in
low-density MDCK cell cultures. MDCK cells expressing
mCherry-actin were seeded on a laminin-coated dish at low
density and allowed to attach. The cells were imaged at 37uCb y
DIC and epifluorescence every 1 min before and after the addition
of 200 nM cucurbitacin I. The movie begins just after the addition
of the compound to the cells. The formation of aggregates of actin
over the following 5 h can be seen.
Found at: doi:10.1371/journal.pone.0014039.s006 (13.96 MB
MOV)
Movie S6 Jasplakinolide causes cessation of migration and
lamellipodial collapse in B16-F1 cells. B16-F1 cells were grown
on a laminin-coated dish overnight. Cells were then imaged at
37uC every 5 min before and after addition of 200 nM
jasplakinolide. After addition, the cells immediately stopped
moving and began to retract their lamellipodia. After 100 min,
the compound was washed out and imaging continued. The cells
recovered and began to move about 4 h later.
Found at: doi:10.1371/journal.pone.0014039.s007 (0.78 MB
MOV)
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